Clinical Trial Update: A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19 [Phase 1]

View source ↗

Summary

A Phase 1 placebo-controlled trial evaluating Bempegaldesleukin (BEMPEG; NKTR-214) plus standard of care in patients with mild COVID-19 has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• bempegaldesleukin (BEMPEG; NKTR-214) (bempegaldesleukin)

Snippet

Sponsor: Nektar Therapeutics | Conditions: Covid-19, Coronavirus Disease 2019 | Phase 1 | Status: COMPLETED | Results posted: 2024-03-12